School of Public Health

Shoultz, David

David A. Shoultz

Affiliate Assistant Professor, Epidemiology
Affiliate Assistant Professor, Global Health


Deputy Director, Global Health, Infectious Disease Development

Education

MBA Seattle University, 2012
PhD Epidemiology, University of Washington, 1997
MS Epidemiology, University of Washington, 1995
BSN University of Washington, 1991

Contact Info

Seattle, WA 98102
Tel: 206-709-3307
dshoultz@path.org

I am interested in global health product discovery, development, and delivery. I am also interested in innovative finance for global health product development. I am eager to collaborate with other faculty members and am available to work with master’s and doctoral students who share my interests and commitment to global health product development.

Dr. David Shoultz is the Global Program Leader for Drug Development at PATH.  PATH is an international organization that drives transformative innovation to save lives and improve health, especially among women and children.  PATH works across five platforms – vaccines, drugs, diagnostics, devices, and system & service innovations.  PATH works with countries and other partners around the world to bring innovation to scale.  PATH’s Drug Development program is working to discover, develop, and deliver safe, effective, and affordable new treatments for diseases disproportionately affecting people in developing countries.

Prior joining PATH in November 2014, David was the director of grantee & partner engagement at the Bill & Melinda Gates Foundation and a member of the foundation’s leadership team.  Having joined the Gates Foundation in 2009, David held several different roles at the foundation, including deputy director in the Global Health Program. He was also the relationship manager for PATH, and served as board member at OneWorld Health, the predecessor to the PATH Drug Development program.

Dr. Shoultz received his bachelor’s degree, MS, and Ph.D from the University of Washington in Seattle. His MBA is from the Albers School of Business & Economics at Seattle University, where he is a faculty member in the Executive MBA Program. For the past 14 years, he has been a member of the affiliate faculty for the departments of Global Health and Epidemiology at the University of Washington. 

Prior to joining the foundation, Dr. Shoultz worked as a member of the senior management team for a number of clinical research organizations, participating in the development of new medicines, including PPD, PRA International, and Biomedical Systems.  

In addition to his role at the Gates Foundation, Dr. Shoultz is on the Board of the Geneva Foundation, where he also serves as the inaugural chair of the Scientific Advisory Committee.  Follow him on Twitter @shoultztweets.

Links

http;//www.path.org

Research Interests

Global health product development.  New medicine development.  Research & development.  Innovative financing for global health R&D.

Other Areas of Involvement

 Member, Board of Directors and Inaugural Chair of the Scientific Advisory Board, the Geneva Foundation - a private, non-profit organization created in 1993 with the sole purpose to support and promote the advancement of military medicine. www.genevausa.org

Publications

Tice AD, Hoaglund PA, Shoultz DA. Risk factors and treatment outcomes in osteomyelitis. J Antimicrob Chemo. 2003 51: 1261-1268.

In The News

Faculty-staff-retiree gifts to the University show depths of connection
University Week, 10/21/2008